Michael Chuong
@MikeChuongMD
Professor, Vice Chair, Medical Director, Dept of Radiation Oncology, Miami Cancer Institute; Chief of GI Radiation Oncology
ID:1162882612005867522
18-08-2019 00:23:29
659 Tweets
1,1K Followers
379 Following
Follow People
Drew Moghanaki π
MD, MPH - Lung Cancer Specialist and Professor, David Geffen School of Medicine at UCLA | Co-Director, Lung Precision Oncology Program, VA Greater Los Angeles
ASTRO
ASTRO is the American Society for Radiation Oncology. Targeting Cancer Care. Patient education info at https://t.co/j4u8EzrwzJ #radonc #medphys #radbio #DEIinRO
Nicholas Zaorsky, MD MS
Vice Chair, Ed, @RadoncUH | Tenured Associate Prof, #RadOnc @cwru | Director, GU Onc, E Cleveland | Prostate, kidney, metastasis, skin, public health |
Dr. Nina Niu Sanford
GI Radiation Oncologist | Boston, @Princeton, @harvardmed, now @UTSWNews in Dallas | buying in bulk | @AAAS IF/THEN | Tweets=own | FCOI: https://t.co/EjwMnJKbth
Amar Kishan
Radiation Oncologist, Professor, Vice Chair of Clinical and Translational Research, and Chief of GU Radiotherapy at UCLA. All views are my own.
Need help from my pancreas surgeon friends π
What is the ~2-3 year local failure rate for upfront resectable #pancreaticcancer +/- chemo?
Surprisingly many prospective trials do not report
Want to design trial based on this
Thanks in advance π
Fear of missing out on our Liver, Pancreas & Upper GI Oligomets Imaging and SBRT course? Tune in LIVE for our Keynote Webinar April 19, 12:45pm EST! tinyurl.com/AEPKeynote Princess Margaret Cancer Centre Radiation Medicine Program
Michael Chuong Dr. Nina Niu Sanford Jeff Ryckman Consider that in LAPC1, where conversion surgery was considered 6 mo after SBRT (7/35), 2 patients achieved pCR while near pCR (isolated viable tumor cells) was obtained in 4 patients. Time really matters..
Michael Chuong Miami Cancer Institute Research Great thread! Thanks for sharing Michael Chuong! Fully share your thoughts regarding the importance of elective CTVs!